The global hepatitis diagnostic test market size was valued at USD 3.9 billion in 2016 and is expected to grow at a CAGR of 6.5% over the forecast period. Rising prevalence of hepatitis diagnostics is primarily diving the growth of the global market. A data published by the World Health ...Read More »
May : 2018The global blood screening market size was valued at USD 1.6 billion in 2015 and is projected to grow at a CAGR of 10.2% over the forecast period. Blood screening is a process in which donated blood is screened for various infectious diseases such as HBV, HCV, HIV1, and HIV2. High growth...Read More »
April : 2018The global zika virus Testing market size was valued at USD 131.9 million in 2016. It is projected to exhibit a CAGR of 7.6% over the forecast period. Involvement of international organizations, such as UNICEF, and national governments in low-income developing regions is one of the key t...Read More »
April : 2018The global non-invasive prenatal testing market size was estimated at USD 1.19 billion in 2015. Advantages associated with the use of these tests such as leading to significant reduction in the number of expensive and risky invasive amniocentesis and Chorionic Villus Sampling (CVS) proce...Read More »
March : 2018The global C-reactive protein test market size was estimated at USD 1.57 billion in 2016 and anticipated to expand at a CAGR of 1.3% over the forecast period. It is driven by high R&D in the field of C-reactive protein (CRP) testing and rising burden of various chronic and inflammato...Read More »
March : 2018The global influenza diagnostics market size was valued at USD 1.91 billion in 2015 and is anticipated to witness a CAGR of 6.4% during the forecast period. Influenza, which is commonly called the flu is an infectious disease of the upper respiratory system caused by the influenza virus....Read More »
March : 2018The global blood testing market size was estimated at USD 51.5 billion in 2015. Confluence of influencing factors, such as accelerated disease R&D, rising prevalence of chronic disease, and consumerism; is anticipated to augment the scope of blood testing services throughout the fore...Read More »
March : 2018The global poultry diagnostic market size was estimated at USD 388.1 million in 2016. Increasing disease outbreaks such as Avian Influenza is vital driver for the substantial growth of the poultry diagnostic market.Poultry disease outbreaks are the prime factor responsible for the signif...Read More »
March : 2018The global primary care POC diagnostics market size was estimated at USD 6.3 billion in 2016.Rapid evolution of point-of-care testing (POCT) holds enormous potential for the growth of both primary and secondary care settings. Rapidly increasing healthcare expenditure within secondary and...Read More »
March : 2018The global malaria diagnostics market size was valued at USD 604.3 million in 2016 and is anticipated to witness a CAGR of 4.5% during the forecast period. Increasing demand for malaria diagnostics in malaria endemic countries and development of technologically advanced and efficient dia...Read More »
February : 2018The Latin America clinical laboratory services market size was estimated at USD 14.4 billion in 2016 and is projected to expand at a CAGR of 7.5% over the forecast period. Rising burden of chronic diseases, coupled with consequent demand for diagnostic tests, is expected to serve as a hi...Read More »
February : 2018The global molecular diagnostics market size was valued at USD 6,451.5 million in 2015 and is anticipated to grow at a CAGR of 12.1% over the forecast period. Advancements in molecular diagnostics have enabled detection of various diseases that could possibly result in severe social and ...Read More »
February : 2018The global neglected tropical diseases diagnosis market size was estimated at USD 5.3 billion in 2016. Formal recognition of Neglected Tropical Diseases (NTDs) in the sustainable development goals as a global target is expected to drive market growth. In the past, NTDs did not receive th...Read More »
February : 2018The global Point of Care (PoC) diagnostics/testing market size was estimated at USD 16.7 billion in 2016. The ability of POC diagnostic tests to render immediate results thus providing improved patient care coupled with rising market penetration of PACS (picture archiving and communicati...Read More »
February : 2018The global drug of abuse testing services market size was estimated at USD 1,465.4 million in 2016. Increase in the number of disorders associated with overuse of illicit substance and enforcement of legislations for Alcohol and Drug (A&D) testing are some of the key factors anticipa...Read More »
December : 2017The global stethoscope market size was valued at USD 327.7 million in 2016 and is expected to grow at a CAGR of 4.7% over the forecast period. The global rise in cardiovascular and pulmonary diseases, increasing healthcare expenditure, and technological advancements such as Bluetooth con...Read More »
November : 2017The global ECG equipment and management system market size was estimated at USD 4.6 billion in 2016. Increasing geriatric population base coupled with increase in cardiac problems, such as ischemic heart disease, heart arrhythmia, heart rhythm disorders and heart attack, is anticipated t...Read More »
November : 2017The global Isothermal Nucleic Acid Amplification Technology (INAAT) market size was valued at USD 1.6 billion in 2016. Increasing demand for INAAT as a molecular testing technique and rising prevalence of infectious diseases are expected to drive the market over the forecast period. Acco...Read More »
August : 2017The global point of care infectious disease diagnostics/testing market size was estimated at USD 1.05 billion in 2016. Driven by latest trends of consumer centric services coupled with high demand for portable and rapid testing devices this market is expected to witness lucrative growth....Read More »
August : 2017The global Structural Heart Imaging (SHI) market size was estimated at USD 10.1 billion in 2016. Global increase in incidence of Congenital Heart Diseases (CHDs) and rising government support to improve accessibility to treatments are expected to be major factors driving growth. CHDs rep...Read More »
August : 2017The global NASH (Non-alcoholic Steatohepatitis) biomarkers market size was valued at USD 200.04 million in 2016 and is expected to witness a CAGR of 30.1% during the forecast period. Growing prevalence of chronic liver conditions is expected to upsurge demand for noninvasive diagnostic t...Read More »
July : 2017The global clinical laboratory services market size was estimated at USD 186.1 billion in 2016. The growing incidence of target infectious diseases is one of the most significant growth drivers for this market. Rise in volume of testing samples is a contributing factor driving demand for...Read More »
June : 2017The global pharmacogenomics technology/theranostics/ CDx market size was estimated at USD 5.62 billion in 2016. Theranostics, are pioneering personalized medicine by predicting prognosis, and pinpointing diagnoses down to the subtype of chronic conditions. Rising cost of healthcare coupl...Read More »
June : 2017The global vitamin D testing market size was estimated at USD 498.1 million in 2016. Global rise in geriatric population coupled with increase in chronic illnesses, such as type 2 diabetes, kidney disease, Crohn's disease, and celiac disease, is anticipated to drive the growth of the mar...Read More »
May : 2017The global biopsy devices market size was estimated at USD 1.0 billion in 2016. Growing prevalence of cancer worldwide and presence of untapped opportunities in emerging economies, especially of Asia Pacific, along with improving healthcare infrastructure in these regions are among the k...Read More »
May : 2017The global histology & cytology market size was estimated at USD 8.6 billion in 2016. Globally, increasing rate of cancer incidence and continuous R&D are expected to be key factors driving the growth. According to the WHO, cancer was the second leading cause of death across the ...Read More »
May : 2017The global blood culture test market size was estimated at USD 3.2 billion in 2016. Escalating rate of approval for new products, including instruments and consumables for diagnosis of Bloodstream Infections (BSI), by regulatory authorities is a major factor contributing to the growth of...Read More »
May : 2017The global cancer diagnostics market size was valued at USD 124.0 billion in 2016 and is expected to grow at a CAGR of 7.2% over the forecast period. Growing prevalence of oncologic cases, constant technological advancements in diagnostics, and increasing demand for effective screening t...Read More »
March : 2017The global kidney function tests market size was valued at USD 1.2 billion in 2016 and is expected to grow at a CAGR of 5.2% over the forecast period. The growing prevalence of chronic kidney diseases is presumed to be responsible for growth attained by this market. The high prevalence i...Read More »
March : 2017The global nucleic acid amplification testing (NAAT) market size was valued at USD 1.78 billion in 2015. Growing demand for the advanced diagnostic measures and increasing investments for development of new biotechnological diagnostic techniques are the key factors propelling the growth ...Read More »
February : 2017The global Autoimmune Disease Diagnostics Market disease diagnostics market size was valued at USD 3.3 billion in the year 2015 and is estimated to reach a value of USD 5.0 billion by 2025, growing with CAGR of 4.1%. Increasing prevalence of autoimmune disorders such as type 1 diabetes i...Read More »
February : 2017The global predictive genetic testing & consumer/wellness genomics market was valued at USD 2.24 billion in 2015. Shifting attention of federal regulatory agencies due to the rising public health concerns for the safety, validity, and effectiveness of genetic tests is anticipated to ...Read More »
January : 2017The U.S. IVD and LDT for autoimmune diseases market was valued at USD 4.0 billion in 2015 and is expected to reach USD 4.74 billion by 2024. The market growth can be attributed to rising occurrence of autoimmune diseases & cancers and technological advances in diagnostic techniques. ...Read More »
November : 2016Lymphoma is a medical term for blood cancer. Development of lymphoma indicates abnormal growth of B or T lymphocytes and also if these cells survive longer than their normal cycle. Lymphoma is generally found in bone marrow, spleen, and other parts that constitute the lymphatic syst...Read More »
Biological therapy consists of using a living organism substance derived either from living organisms or laboratory produced variations of the substances to treat a particular disease. Biological therapies generally comprise interleukins, interferons, monoclonal antibodies, vaccines and ...Read More »
The global cervical cancer diagnostic market was valued at USD 7 billion in 2015 and is projected to grow at a CAGR of 5.9% over the forecast period. Women between the age group of 20 and 60 years are usually more prone to this ailment, which is expected to increase the screening and dia...Read More »
September : 2016The global tuberculosis diagnostics market was valued at USD 2.1billion in 2015 and is expected to witness a CAGR of 4.1% over the forecast period.The rising burden of tuberculosis is one of the biggest concerns among the government and healthcare agencies....Read More »
September : 2016The cardiac biomarkers market was estimated to reach USD 4.7 billion in 2015. Cardiac biomarkers refer to the substances released in the bloodstream due to heart-related damage or stress, mainly caused by insufficient blood flow. The quantification of biomarkers is employed for the diagn...Read More »
September : 2016The Europe molecular diagnostics market size was valued at USD 1,750.0 million in 2015 and is expected to exhibit attractive growth over the forecast period. As a developed region, technology enhancement is enabling the European market to further grow through the development of new produ...Read More »
August : 2016The North America molecular diagnostics market was valued at over USD 3.0 billion in 2015. Growth is triggered by the increase in per capita healthcare expenditures and technologically advanced healthcare infrastructure. Growing awareness amongst patients also serves as one of the major ...Read More »
August : 2016The global critical care diagnostic (CCD) market size was estimated at USD 837.6 million in 2015. These diagnostic tests deal with the specialized care and diagnosis of life-threatening diseases occurring in patients....Read More »
August : 2016North America point of care diagnostics market was valued at USD 6.84 billion in 2015. Growing awareness for home healthcare coupled with rapid and cost-effective results provided by POC diagnostics is anticipated to propel market growth. ...Read More »
August : 2016The Asia Pacific In Vitro Diagnostics (IVD) market was estimated at USD 12.1 billion in 2015. The increase in number of infectious and chronic diseases, the rising awareness levels of advanced diagnostic solutions as well as technological developments are estimated to be some major factors propelling the growth of t...Read More »
August : 2016Latin America point of care diagnostics market size was valued at USD 1.19 billion in 2015. Hospitals, assisted living homecare facilities and other healthcare facilities are noted to have increased adoption rates of POC diagnostics in Latin America to provide rapid and effective diagnos...Read More »
August : 2016The global Computer Aided Detection (CAD) market size was valued at USD 405.9 million in 2014. Increasing cancer prevalence and rising awareness in the population for regular health check-ups are the most significant drivers of the global CAD industry....Read More »
August : 2016The North America and Europe stroke diagnostics market was estimated to be USD 800.0 million in 2015. Stroke is recognized as the world’s second leading cause of death and is responsible for 11.3% of the total deaths around the globe. The U.S. recognizes it as the third leadin...Read More »
July : 2016The global Single Cell analysis market was valued at USD 1,183.7 million in 2015. The rising number of investments and government funds deployed for research and development (R&D) activities in the field of medical diagnostics, availability of technically advanced products, and the r...Read More »
July : 2016The global lung cancer diagnostics market size was estimated at USD 1.63 billion in 2015.Technological advancements pertaining to tumor diagnosis contribute towards the market growth. The need for more efficient diagnostic systems is due to the fact that only 15% of the lung cancer cases...Read More »
June : 2016The global in-vitro colorectal cancer screening tests market was valued at USD 559.3 million in 2014 and is likely to grow at a CAGR of 5.2% over the forecast period....Read More »
June : 2016Global point of care molecular diagnostics market was valued at USD 1.2 billion in 2015. Ongoing R&D to miniaturize extraction, purification, amplification and detection in molecular tests is expected to be a positive influence on growth in demand for POC devices in this market. ...Read More »
June : 2016Growing prevalence of cancer coupled with growing demand for personalized medicine are anticipated to propel the growth of the tissue diagnostic market over the forecast period. Tissue diagnostic involves monitoring, prognosis and management of different stages of cancer, especially pros...Read More »
May : 2016The global urinalysis market size was estimated at USD 1.37 billion in 2015.The magnitude of the target diseases, such as UTI, kidney diseases, and diabetes, is immense with the occurrence of millions of new cases every year. Urinalysis is used as the primary diagnostic tool for the diag...Read More »
April : 2016Pain in cancer may come from compressing or infiltrating nearby body parts, from treatments and diagnostic procedures or from skin, nerve, and the other changes caused by a hormone imbalance or immune response. Most chronic pain is caused by the illness and most acute pain is caused by t...Read More »
The global glucose biosensor market was estimated at USD 15.3 billion in 2015. Increasing incidence of diabetes across the globe is expected to be a key factor driving market growth....Read More »
February : 2016The European Real-time Polymerase Chain Reaction (qPCR) market was valued at over USD 182 million in 2014....Read More »
February : 2016The global paper diagnostics market was valued at USD 4,700 million in 2014 and is anticipated to grow at CAGR of 7.5% over the forecast period. Rising prevalence of infectious diseases such as HIV, malaria, tuberculosis is responsible for the overall growth of paper diagnostic market ov...Read More »
February : 2016Global IVD infectious disease market was valued at over USD 13 billion in 2014 and is expected to grow at a CAGR of 8.2% over the forecast period....Read More »
January : 2016Global STD diagnostics market size was valued at over USD 17 billion in 2014. Increase in patient awareness such as education campaigns and growing government initiatives are anticipated to drive market growth. ...Read More »
January : 2016The global allergy diagnostics and therapeutics market size was valued at USD 25,752.6 million in 2014. Increasing incidences of allergic diseases coupled with demand for in vitro diagnostic blood test is posed to drive the industry growth in coming years. ...Read More »
January : 2016The global HIV diagnostics market was valued at USD 2,173.8 million in 2014 and is expected to grow at a CAGR of 9.5% over the forecast period....Read More »
January : 2016The heart attack diagnostics market was estimated to reach USD 6.6 billion in 2015. Heart attack or myocardial infarction is a form of cardiovascular disease (CVD) and it occurs when oxygenated blood flow to the heart muscle is reduced or cut off, which is also termed as myocardial ische...Read More »
July : 2015Rising incidences of genetic disorders that give rise to wide variety of independent diagnostic procedures globally is predominantly driving the growth of the global genetic disorder diagnostic market. Additionally, increasing awareness about prenatal diagnosis, rising attempt to improve...Read More »
The global diabetes treatment market is undergoing significant transition driven by the advent of new analytical technologies and developments in diabetes treatment. There has been a drastic increase in the incidents of diabetes worldwide, owing to the rising level of sedentary lifestyle...Read More »
Increasing prevalence of respiratory diseases owing to the growing aging population and increasing pathogens in the environment has been the key factor driving the asthma and chronic obstructive pulmonary disease (COPD) market globally. Asthma & COPD are chronic respiratory diseases ...Read More »
Companion diagnostics is a form of In Vitro Diagnostics which provides healthcare practitioners with the information about the patient’s response to a particular treatment. ...Read More »
Cancer/Tumour profiling is obtaining knowledge about patient’s cancer/tumour profile that is able to identify genomic alterations which can help physician to select an appropriate therapy which can result successful treatment for the patient....Read More »
Tuberculosis is an infectious or sometimes fatal disease with mycobacteria its major cause. In common tuberculosis attacks the lungs, or even other parts of the body such as genitourinary system, lymphatic system and central nervous system. ...Read More »
Point of care (POC) diagnosis refers to conducting diagnostic tests near the site of patient care. The Asia Pacific PoC diagnostics market is driven by four major factors namely growing geriatric population base in countries such as Japan and China, rising prevalence of target diseases, ...Read More »
April : 2014The G-protein coupled receptors (GPCRs) market is expected to witness a lucrative growth during the forecast period owing to the major factors such as increasing demand of GPCRs in ADME toxicity studies and drug discovery processes and ongoing patent expiration of blockbuster drug molecu...Read More »
Global non invasive cancer diagnostics and technologies market is anticipated to show lucrative growth over the forecast period owing to factor such as rising demand for minimally invasive therapeutics and diagnosis for the treatment of cancer....Read More »
Global orthopedic extremity market is expected to witness lucrative growth over the forecast period owing to rising global geriatric population base, coupled with increasing life expectancy rate. ...Read More »
Global human papilloma virus testing market is expected to witness lucrative growth over the forecast period owing to increasing prevalence of cervical cancer. Rise in global geriatric female population is also one of the key drivers for market growth due to the presence of co-morbiditie...Read More »
Global diagnostic electrocardiography devices market is expected to witness lucrative growth over the forecast period owing toincreasing prevalenceof cardiovascular diseases coupled with rising geriatric population base....Read More »
The global scenario for the dental diagnostic and surgical equipment market is expected to boost over the forecast period. Rising inclination towards junk food consumption and improper eating habits by individuals along with augmenting demand for cosmetic dentistry are considered to be t...Read More »